Answers are grounded in this paper and cite their sources.
The real‐time, personalized and highly sensitive early‐stage diagnosis of disease remains an important challenge in modern medicine. With the ability to interact with matter at the nanoscale, the development of nanotechnology architectures and materials could potentially extend subcellular and molecular detection beyond the limits of conventional diagnostic modalities. At the very least, nanotechnology should be able to dramatically accelerate biomarker discovery, as well as facilitate disease monitoring, especially of maladies presenting a high degree of molecular and compositional heterogeneity. This article gives an overview of several of the most promising nanodevices and nanomaterials along with their applications in clinical practice. Significant work to adapt nanoscale materials and devices to clinical applications involving large interdisciplinary collaborations is already underway with the potential for nanotechnology to become an important enabling diagnostic technology. WIREs Nanomed Nanobiotechnol 2011 3 11–32 DOI: 10.1002/wnan.82 This article is categorized under: Diagnostic Tools > Diagnostic Nanodevices Diagnostic Tools > In Vivo Nanodiagnostics and Imaging
No takes yet. Share an insight, caveat, or question.
Hu et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: